Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Esomeprazole on Trazpiroben PK in Healthy Adults
NCT03849690Phase 1Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of trazpiroben in gastroparesis, sponsored by Millennium Pharmaceuticals. Primary endpoints: Maximum Observed Plasma Concentration for TAK-906, Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for TAK-906 and 1 more. Started Feb 2019; status: completed.
02
Drugs
trazpiroben
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT03849690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849690.